An intronless gene encoding an additional human serotonin (5-1T) 5-HTificee receptor subtype was isolated from a human genomic library with probes obtained from degenerate PCR primers used to amplify 5-liT-receptorspecific sequences. The highest degree of homology was found with the 5-HT1E subtype (70%) and the 5-HTlDa (63%) and 5-HTlDp3 (60%) receptors. RNA for this gene was detected in the human brain but was not detected in kidney, liver, spleen, heart, pancreas, and testes. High-affinity (Kd = 9.2 nM) 3H-labeled 5-HT binding was detected. Competition studies revealed the following rank order of potencies for serotonergic ligands: 5-HT > sumatriptan >> 5-carboxyamidotryptamine > 8-hydroxy-2(di-1-propylamino)tetralin > spiperone. 5-HT produced a dose-dependent inhibition of forskolin-stlmulated cAMP accumulation (EC50 = 7.9 nM) in transfected cells.
(5-HT1F) coupled to the inhibition of adenylate cyclase.
The diverse physiological actions of serotonin (5-HT) are mediated by at least four receptor classes: 5-HTlike, 5-HT2, 5 -HT3, and 5-HT4 (1-3). The 5-HT1like class appears the most heterogeneous. Four human genes encoding 5-HT1.like receptors have been cloned: 5-HT1A (4, 5) , 5-HTDa (6, 7) , 5-HT1D, (7) (8) (9) , and 5-HT1E (10) (11) (12) . The 5-HT1B receptor has been cloned (13) (14) (15) and is homologous to the 5-HT1Dp receptor (14) . These 5-HT1like receptors all share an amino acid homology of at least 50o, high affinity for 3H-labeled 5-HT ([3H]5-HT), and coupling to the inhibition of adenylate cyclase activity as a primary coupling pathway. Many additional 5-HT-mediated functional responses do not seem to correlate with any of these cloned receptor subtypes (16, 17) .
We have used a PCR cloning approach to isolate a human gene that encodes another 5-HT1-lke, receptor, termed 5-HT1F, with a pharmacological profile distinct from any serotoner- EXPERIMENTAL PROCEDURES PCR. The third (III) and fifth (V) transmembrane (TM) domains of the following receptors were used to synthesize degenerate primers: 5-HT1A, 5-HT1c, 5 -HT2, and the 5-HTD10/p receptors. Primers 3.17 and 5.5 [(5'-TGGAATTC-TGYGYIATHKCICTGGAYMGSTA-3') and (5'-CATIA-VIRIIARIGGDATRWARAAIGC-3')] were used to amplify 5 ,ug of poly(A)+ RNA from rat brain that was reversetranscribed by reverse transcriptase (avian myeloblastosis virus). PCR was done on single-stranded cDNA as follows:
940C for 1 min, 500C for 2 min, and 72TC for 3 min for 40 cycles. After PCR, 90 A.l of the reaction was phenol/ chloroform-extracted and precipitated, treated with T4 DNA polymerase, and digested with EcoRI before separation on a 1% agarose gel. The DNA fragment was isolated from the gel, kinased, and cloned into pBluescript. Recombinant clones were analyzed by sequencing. One clone, designated S51, was chosen for further study.
Cloning and Sequencing. A human lymphocyte genomic library (Stratagene) was screened by using the rat S51 fragment as a probe. The probe was labeled with 32P by the method of random priming (18) and hybridized (19) . For subcloning and further Southern blot analysis, DNA was inserted into pUC18 (Pharmacia). Nucleotide sequence analysis was done by the Sanger dideoxynucleotide chaintermination method (20) on denatured double-stranded plasmid templates with Sequenase (United States Biochemical).
Expression. The coding region of clone hL16a was cloned into vector pcEXV-3 (21) , and stable cell lines were obtained by cotransfection (19) . One LM(tk-) cell line, L-1F-3, was selected for binding studies; one NIH 3T3 stable cell line N-1F-6 was selected for functional studies.
Membrane Preparation. Membranes were prepared from stably transfected LM(tk-) cells as described (19) . Protein concentrations were determined by the method of Bradford (22) . 
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LGVS Tissue Localiation Studies. Human tissues (National Disease Research Institute) were homogenized, and the total RNA was extracted (24) . cDNA was prepared from 5 ,ug of total RNA with random hexanucleotide primers (500 pmol) using Superscript reverse transcriptase (BRL) in PCR reaction buffer (Cetus) containing 1 mM dNTPs, at 42°C for 1 hr. An aliquot of the first-strand cDNA was diluted (1:5) (10) (11) (12) (Fig. 1) . The TM amino acid identity of hL16a to other known 5-HT1 receptors is as follows: 5-HTlE (70%), (63%), 5-HT1D,0 (60%), and 5-HTlA (53%). (Fig.  2B) . 5-HT displayed the highest affinity (Table 1) ,tM forskolin increased the basal cAMP release (0.036 ± 0.0050 pmol/ml per 10 min) by -10-fold. 5-HT inhibited the response (Fig. 3) with an EC50 value of 7.9 + 0.76 nM and a maximum percentage inhibition of FSAC (Emx value) of 74 + 4.6 (mean ± SEM, n = 10). The 5-HT response (1 ,uM) was completely blocked by the nonselective antagonist methiothepin (10 ,uM) . This antagonism was surmountable (Fig.  3) , indicating probable competitive antagonism. The dose shift produced by methiothepin yielded an apparent Kb of 438 + 14 nM, consistent with the K, for this compound (Table 1) .
RESULTS
No direct effect of methiothepin was seen.
No other compound tested in this study was an antagonist. In addition, no evidence for coupling ofthis receptor to inositol phospholipid turnover was detected at a dose of 10 ,M 5-HT. Expression of the 5-HT1F transcripts was analyzed from PCR-RNA blots and in situ hybridization studies. By PCR, we detected 5-HT1F receptor mRNA in the human brain, uterus (endometrium and myometrium), and mesentery (Fig.  4) but did not detect it in kidney, liver, spleen, heart, pancreas, or testes. In in situ hybridization experiments, we observed 5-HT1F transcripts in lamina V of frontal cortex (Fig. SA) in large pyramidal cells (Fig. SD) . Moderate labeling was also detected over layer VI nonpyramidal neurons. In both layer V and layer VI, the labeling was most evident in dorsal sensorimotor neocortex and in cingulate and retrosplenal cortices (Fig. SC) . The pyramidal cells in the piriform cortex were heavily labeled, as were large neurons in the raphe nuclei (Fig. 5E) . Hippocampal pyramidal cells in CA1-CA3 were moderately labeled, as were the granule cells in the dentate gyrus, and some neurons in the nucleus of the solitary tract. Little labeling was found in the thalamus and hypothalamus.
DISCUSSION
The pharmacological profile obtained from cells expressing gene hL16a (Table 1) indicates that it encodes a member of the 5-HTllike receptor subfamily, as 5-CT is an agonist, and methiothepin is an antagonist (27) . As for the 5-HT1E receptor, its closest genetic relative (Fig. 1) , the affinity for these compounds is relatively low. Nonetheless, the high affinity for sumatriptan, 5-methoxy-N,N-dimethyltryptamine, methysergide, and other compounds from diverse structural classes (Table 1) The only "5-HT1 receptor" that does not couple to adenylate cyclase is the 5-HTic receptor (31) , which is now considered a member of the 5-HT2 subfamily (2) . Why so many different 5-HT1 receptor subtypes have been maintained in the genome is not at all clear. Possible explanations include different midpoints for activation by 5-HT under physiological conditions, different desensitization rates, different efficiencies or kinetics of coupling to adenylate cyclase inhibition, coupling to diverse adenylate cyclases, different developmental regulation, coupling to separate ion channels, or coupling to ion-channel regulation rather than adenylate cyclase regulation as a primary physiological pathway.
Localization of transcripts for this receptor indicates a relatively selective tissue distribution. Of tissues reported here, the 5-HT1F receptor was detected only in the brain, uterus, and mesentery. The possible role of this receptor in uterine or vascular function is intriguing. Future studies defining the specific cell type(s) in these tissues that express the receptor may provide insight into its function in the periphery. In the brain, the expression had a limited distribution compared with that of other 5-HT receptors (9) . In the neocortex, labeling of layer V pyramidal neurons may indicate a functional role for the 5-HT1F receptor protein in the integration of sensorimotor (somatodendritic; frontal cortex) or afferent information associated with limbic functions (somatodendritic; cingulate/retrosplenial cortex), or in spinal cord processes (axonal). Strong labeling was also detected in hippocampal pyramidal cells, in several thalamic nuclei, and in the dorsal raphe. The detection of transcripts for this gene in the dorsal raphe nucleus indicates a possible role as an autoreceptor. This localization is shared by both the 5-HTID' and 5-HT1Ds receptors (9) . Such heterogeneity of autoreceptors has recently been described (32 
